Drosophila melanogaster as a model for understanding polyADP-ribosylation

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Review

Masanao Miwa^1,2,*, Shuji Hanai², Sachiko Yamashita¹, Masakazu Tanaka³, Kazuhiko Uchida²

Show Less

¹ Nagahama Institute of Bio-Science and Technology, Nagahama Shiga 526-0829, Japan

² Institute of Basic Biological Sciences, University of Tsukuba, Tsukuba Ibaraki 305-8575, Japan

³ Center for Chronic Viral Diseases, Kagoshima University, Kagoshima, Kagoshima 890-8544, Japan

Send correspondence to: Masanao Miwa, Nagahama Institute of Bio-Science and Technology, 1266 Tamura-cho, Nagahama, Shiga 526-0829, Japan, Tel: 81-749-64-8100, Fax: 81-749-64-8140, E-mail: m_miwa@nagahama-i-bio.ac.jp

Front. Biosci. (Landmark Ed) 2020, 25(1), 118–133; https://doi.org/10.2741/4797

Published: 1 January 2020

(This article belongs to the Special Issue Cutting edge of insect biomedical science)

Abstract

PolyADP-ribosylation is a post-translational modification which is involved in various physiological processes including maintenance of genome stability through DNA repair, regulation of transcription, and development. This process is also involved in pathological events such as cell death. Here, we review the effect of polyADP-ribosylation in signal transduction pathways in Drosophila melanogaster system. It is hoped that such an insight paves the way to develop therapeutics for human diseases.

Keywords

Drosophila melanogaster

ADP-ribosylation

PolyADP-ribosylation

Neurodegenerative disease

PARP

Review

Figures

Figure 1

Previous article in this issue

Next article in this issue

Front. Biosci. (Landmark Ed) Print ISSN 2768-6701 Electronic ISSN 2768-6698